PDGFRA and gastrointestinal stromal tumor: The SDH-competent GIST group includes a large proportion of patients who may harbor either KIT or PDGFRA mutations and also mutations in genes involved in the RAS–MEK–MAPK pathway, and translocations involving NTRK or FGFR genes [7,51].